In vivo activity of recombinant humanized monoclonal antibody 2C4 in xenografts is independent of tumor type and degree of HER2 overexpression
- 30 November 2002
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 38, S149
- https://doi.org/10.1016/s0959-8049(02)81150-9